PMV Pharma
Pre-clinicalPMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.
Founded
2013
Focus
Small Molecules
About
PMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.
Funding History
4Total raised: $362M
IPO$175MUndisclosedOct 30, 2020
Series C$100MRA Capital ManagementJun 15, 2020
Series B$62MOrbiMedJun 15, 2017
Series A$25MOrbiMedJun 15, 2015
Company Info
TypePrivate
Founded2013
LocationCranbury, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile